QuidelOrtho (QDEL) Short-term Investments (2022 - 2023)
QuidelOrtho recorded quarterly Short-term Investments of $48.4 million in Q4 2023, up 10.25% quarter-over-quarter from $43.9 million in Q4 2023, and down 7.1% year-over-year from $52.1 million in Q4 2022.
QuidelOrtho's Short-term Investments history runs 2 years deep, the most recent figure standing at $48.4 million for Q4 2023.
- In Q4 2023, Short-term Investments fell 7.1% year-over-year to $48.4 million; the TTM figure through Dec 2023 stood at $48.4 million (down 7.1% YoY), while the FY2023 annual figure was $48.4 million, down 7.1% from the prior year.
- Short-term Investments came in at $48.4 million for Q4 2023 at QuidelOrtho, up from $43.9 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $52.5 million in Q3 2022 to a low of $25.7 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | QuidelOrtho | 898.19 Mn | 757.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 48.40 Mn |
| Oct 1, 2023 | 43.90 Mn |
| Jul 2, 2023 | 45.10 Mn |
| Apr 2, 2023 | 42.80 Mn |
| Jan 1, 2023 | 52.10 Mn |
| Oct 2, 2022 | 51.80 Mn |
| Jul 3, 2022 | 52.50 Mn |
| Jan 2, 2022 | 25.70 Mn |